| mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
-0.0037 |
0.9 |